JPY829.00
2.98% today
Tokyo, Jun 03, 08:15 am CET
ISIN
JP3495000006
Symbol
4506
Index
Sector
Industry

Sumitomo Dainippon Pharma Target price 2025 - Analyst rating & recommendation

Sumitomo Dainippon Pharma Classifications & Recommendation:

Buy
14%
Hold
43%
Sell
43%

Sumitomo Dainippon Pharma Price Target

Target Price JPY681.43
Price JPY840.00
Deviation
Number of Estimates 7
7 Analysts have issued a price target Sumitomo Dainippon Pharma 2026 . The average Sumitomo Dainippon Pharma target price is JPY681.43. This is lower than the current stock price. The highest price target is
JPY1,200.00 42.86%
register free of charge
, the lowest is
JPY410.00 51.19%
register free of charge
.
A rating was issued by 7 analysts: 1 Analysts recommend Sumitomo Dainippon Pharma to buy, 3 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sumitomo Dainippon Pharma stock has an average upside potential 2026 of . Most analysts recommend the Sumitomo Dainippon Pharma stock at Sell or hold.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Revenue Billion JPY 398.83 366.60
26.79% 8.08%
EBITDA Margin 13.86% 24.32%
130.72% 75.49%
Net Margin 5.93% 13.18%
105.92% 122.42%

7 Analysts have issued a sales forecast Sumitomo Dainippon Pharma 2026 . The average Sumitomo Dainippon Pharma sales estimate is

JPY367b
Unlock
. This is
8.08% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
JPY410b 2.80%
Unlock
, the lowest is
JPY336b 15.78%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 JPY399b 26.79%
2026
JPY367b 8.08%
Unlock
2027
JPY366b 0.28%
Unlock
2028
JPY389b 6.53%
Unlock
2029
JPY460b 18.09%
Unlock
2030
JPY436b 5.23%
Unlock

6 Analysts have issued an Sumitomo Dainippon Pharma EBITDA forecast 2026. The average Sumitomo Dainippon Pharma EBITDA estimate is

JPY89.2b
Unlock
. This is
61.32% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
JPY101b 82.74%
Unlock
, the lowest is
JPY78.3b 41.67%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 JPY55.3b 138.95%
2026
JPY89.2b 61.32%
Unlock
2027
JPY46.8b 47.53%
Unlock
2028
JPY50.5b 8.03%
Unlock
2029
JPY102b 101.82%
Unlock
2030
JPY81.4b 20.20%
Unlock

EBITDA Margin

2025 13.86% 130.72%
2026
24.32% 75.49%
Unlock
2027
12.80% 47.37%
Unlock
2028
12.98% 1.41%
Unlock
2029
22.18% 70.88%
Unlock
2030
18.68% 15.78%
Unlock

4 Sumitomo Dainippon Pharma Analysts have issued a net profit forecast 2026. The average Sumitomo Dainippon Pharma net profit estimate is

JPY48.3b
Unlock
. This is
104.47% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
JPY52.4b 121.71%
Unlock
, the lowest is
JPY40.1b 69.61%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 JPY23.6b 107.50%
2026
JPY48.3b 104.47%
Unlock
2027
JPY12.4b 74.31%
Unlock
2028
JPY27.1b 118.42%
Unlock
2029
JPY57.2b 111.06%
Unlock

Net Margin

2025 5.93% 105.92%
2026
13.18% 122.42%
Unlock
2027
3.40% 74.20%
Unlock
2028
6.96% 104.71%
Unlock
2029
12.45% 78.88%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Earnings Per Share JPY 59.49 121.63
107.50% 104.45%
P/E 6.62
EV/Sales 1.55

4 Analysts have issued a Sumitomo Dainippon Pharma forecast for earnings per share. The average Sumitomo Dainippon Pharma EPS is

JPY121.63
Unlock
. This is
104.45% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
JPY131.89 121.70%
Unlock
, the lowest is
JPY100.90 69.61%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 JPY59.49 107.50%
2026
JPY121.63 104.45%
Unlock
2027
JPY31.25 74.31%
Unlock
2028
JPY68.26 118.43%
Unlock
2029
JPY144.06 111.05%
Unlock

P/E ratio

Current 13.53 3,617.47%
2026
6.62 51.08%
Unlock
2027
25.76 289.12%
Unlock
2028
11.79 54.23%
Unlock
2029
5.59 52.59%
Unlock

Based on analysts' sales estimates for 2026, the Sumitomo Dainippon Pharma stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.42 12.88%
2026
1.55 9.00%
Unlock
2027
1.55 0.28%
Unlock
2028
1.46 6.12%
Unlock
2029
1.23 15.32%
Unlock
2030
1.30 5.53%
Unlock

P/S ratio

Current 0.76 95.63%
2026
0.82 8.78%
Unlock
2027
0.83 0.29%
Unlock
2028
0.78 6.13%
Unlock
2029
0.66 15.32%
Unlock
2030
0.69 5.51%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today